Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas

Virology Journal

Volumn 7, Issue , 2010, Pages

  Jia, Yuping ^a   Wang, Yun ^a   Chao, Yan ^a   Jing, Yongzheng ^b   Sun, Zhifu ^c   Luo, Bing ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b Department of Central Laboratory   (China)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRLF1 GENE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA BINDING; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; NONHUMAN; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STOMACH CARCINOMA; TRANSACTIVATION; TUMOR BIOPSY; VIRUS GENE; VIRUS ISOLATION; VIRUS REPLICATION; CARCINOMA; CHEMISTRY; CLUSTER ANALYSIS; DNA SEQUENCE; EPSTEIN BARR VIRUS INFECTION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; PHARYNX CANCER; PHYLOGENY; STOMACH TUMOR; VIROLOGY;

HUMAN HERPESVIRUS 4;

BRLF1 PROTEIN, HUMAN HERPESVIRUS 4; IMMEDIATE EARLY PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS DNA;

CARCINOMA; CLUSTER ANALYSIS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; PHARYNGEAL NEOPLASMS; PHYLOGENY; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; TRANS-ACTIVATORS;

EID: 78649330755     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-341     Document Type: Article

References (36)

1. Infectious agents and gastric tumours. An increasing role for Epstein-Barr virus. I Mladenova R Pellicano, Panminerva Med 2003 45 183 188 14618116
2. Epstein-Barr virus: 40 years on. LS Young AB Rickinson, Nat Rev Cancer 2004 4 757 768 10.1038/nrc1452 15510157
3. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. MS Wu CT Shun CC Wu TY Hsu MT Lin MC Chang HP Wang JT Lin, Gastroenterology 2000 118 1031 1038 10.1016/S0016-5085(00)70355-6 10833477
4. Detection of Epstein-Barr virus by PCR and expression of LMP1, p53, CD44 in gastric cancer. MA Lee YS Hong JH Kang KS Lee JY You KY Lee CH Park, Korean J Intern Med 2004 19 43 47 15053043
5. The Epstein Barr virus and gastric carcinoma. N Andal P Shanthi KB Krishnan V Taralaxmi, Indian J Pathol Microbiol 2003 46 34 36 15027715
6. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. M Fukayama Y Hayashi Y Iwasaki J Chong T Ooba T Takizawa M Koike S Mizutani M Miyaki K Hirai, Lab Invest 1994 71 73 81 8041121
7. Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma. Y Wang B Luo LP Yan BH Huang P Zhao, World J Gastroenterol 2005 11 3234 3239 15929173
8. Reactivation of Epstein-Barr virus from latency. W Amon PJ Farrell, Rev Med Virol 2005 15 149 156 10.1002/rmv.456 15546128
9. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. T Ragoczy L Heston G Miller, J Virol 1998 72 7978 7984 9733836
10. Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation. E Manet A Rigolet H Gruffat JF Giot A Sergeant, Nucleic Acids Res 1991 19 2661 2667 10.1093/nar/19.10.2661 1645863
11. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. J Countryman G Miller, Proc Natl Acad Sci USA 1985 82 4085 4089 10.1073/pnas.82.12.4085 2987963
12. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. E Grogan H Jenson J Countryman L Heston L Gradoville G Miller, Proc Natl Acad Sci USA 1987 84 1332 1336 10.1073/pnas.84.5.1332 3029778
13. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. CM Rooney DT Rowe T Ragot PJ Farrell, J Virol 1989 63 3109 3116 2542618
14. trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. K Takada N Shimizu S Sakuma Y Ono, J Virol 1986 57 1016 1022 3005608
15. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. R Feederle M Kost M Baumann A Janz E Drouet W Hammerschmidt HJ Delecluse, EMBO J 2000 19 3080 3089 10.1093/emboj/19.12.3080 10856251
16. Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes. T Ragoczy G Miller, J Virol 1999 73 9858 9866 10559298
17. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. S Zalani E Holley-Guthrie S Kenney, Proc Natl Acad Sci USA 1996 93 9194 9199 10.1073/pnas.93.17.9194 8799177
18. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. AL Adamson D Darr E Holley-Guthrie RA Johnson A Mauser J Swenson S Kenney, J Virol 2000 74 1224 1233 10.1128/JVI.74.3.1224-1233.2000 10627532
19. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. CD Darr A Mauser S Kenney, J Virol 2001 75 6135 6142 10.1128/JVI.75.13.6135-6142.2001 11390615
20. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. M Rowe AL Lear D Croom-Carter AH Davies AB Rickinson, J Virol 1992 66 122 131 1309242
21. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. NM Steven NE Annels A Kumar AM Leese MG Kurilla AB Rickinson, J Exp Med 1997 185 1605 1617 10.1084/jem.185.9.1605 9151898
22. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes. S Pepperl G Benninger-Doring S Modrow H Wolf W Jilg, J Virol 1998 72 8644 8649 9765404
23. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. CM Chang KJ Yu SM Mbulaiteye A Hildesheim K Bhatia, Virus Res 2009 143 209 221 10.1016/j.virusres.2009.07.005 19596032
24. Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. JL Hsu SL Glaser, Crit Rev Oncol Hematol 2000 34 27 53 10.1016/S1040-8428(00)00046-9 10781747
25. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. MS Zeng DJ Li QL Liu LB Song MZ Li RH Zhang XJ Yu HM Wang I Ernberg YX Zeng, J Virol 2005 79 15323 15330 10.1128/JVI.79.24. 15323-15330.2005 16306603
26. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. ST Cheung DP Huang AB Hui KW Lo CW Ko YS Tsang N Wong BM Whitney JC Lee, Int J Cancer 1999 83 121 126 10.1002/(SICI)1097-0215(19990924) 83:1<121::AID-IJC21>3.0.CO;2-F 10449618
27. A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. ST Oh JS Seo UY Moon KH Kang DJ Shin SK Yoon WH Kim JG Park SK Lee, Virology 2004 320 330 336 10.1016/j.virol.2003.12.005 15016554
28. Identification of CD8+ T-cell epitopes specific for immediate-early transactivator Rta of Epstein-Barr virus. H Yu N Srinivasan E Ren S Chan, Hum Immunol 2005 66 483 493 10.1016/j.humimm.2005.01.017 15935885
29. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis. P Feng EC Ren D Liu SH Chan H Hu, J Gen Virol 2000 81 2417 2423 10993929
30. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China. KM Ji CL Li G Meng AD Han XL Wu, Arch Virol 2008 153 1949 1953 10.1007/s00705-008-0195-6 18807115
31. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. R Gavioli PO De Campos-Lima MG Kurilla E Kieff G Klein MG Masucci, Proc Natl Acad Sci USA 1992 89 5862 5866 10.1073/pnas.89.13.5862 1321426
32. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. R Khanna SR Burrows MG Kurilla CA Jacob IS Misko TB Sculley E Kieff DJ Moss, J Exp Med 1992 176 169 176 10.1084/jem.176.1.169 1377222
33. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. RJ Murray MG Kurilla JM Brooks WA Thomas M Rowe E Kieff AB Rickinson, J Exp Med 1992 176 157 168 10.1084/jem.176.1.157 1319456
34. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. H Knecht E Bachmann P Brousset K Sandvej D Nadal F Bachmann BF Odermatt G Delsol G Pallesen, Blood 1993 82 2937 2942 8219183
35. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. M Sugiura S Imai M Tokunaga S Koizumi M Uchizawa K Okamoto T Osato, Br J Cancer 1996 74 625 631 8761381
36. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. K Ikuta Y Satoh Y Hoshikawa T Sairenji, Microbes Infect 2000 2 115 120 10.1016/S1286-4579(00)00277-X 10742683